Warren Buffett, the paragon of value investing, has sold billions of dollars of put options to generate income for his Berkshire Hathaway portfolio. Here's how it's done. Read More

You can still reap profits from a stock that drops after you buy it, even if it never gets back to your original purchase price. Read More

Mid-cap stocks are poised to outperform in 2019 because they are cheaper than large-cap stocks and less susceptible to trade war collateral damage. Read More

With the stock market looking shaky, now's a good time to buy put options on these four stocks that appear overvalued and likely to fall. Read More

If history repeats itself, chip stocks should be fully recovered before the end of this year. After that, which sector will the DCF models target next? Read More

Believe it or not, this seemingly stodgy “old tech” copier company has delivered a 57% total return through the first 10 weeks of 2019. Read More

With FDA Chief Scott Gottlieb's departure, we're already seeing big price swings in stocks that may be affected by a change in FDA policy towards tobacco and health care companies. Read More

Given the stock market’s erratic behavior, a lot of money can be made in these three beaten-down stocks that could move strongly in the weeks to come. Read More

We sift through the Oracle of Omaha’s voluminous writings to see what they can tell us about picking winning stocks. Read More

If you want to play the biotech lottery, you need to pinpoint the companies that stand a better-than-average chance of beating the odds. Read More